United States· US:82046-054_22f1f4f3-3196-493c-b6f1-8e3ee7b13a62
Lancome Paris Renergie HPN 300 Peptide Sunscreen Broad Spectrum SPF 25 High-Performance Day
A medicinal product containing avobenzone; octisalate; octocrylene, registered in United States by L'Oreal USA Products Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AVOBENZONE; OCTISALATE; OCTOCRYLENE
- Manufacturer
- L'Oreal USA Products Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1182046054011 JAR in 1 CARTON (82046-054-01) / 30 mL in 1 JAR
- ndc1182046054021 JAR in 1 CARTON (82046-054-02) / 50 mL in 1 JAR
- ndc1182046054031 JAR in 1 CARTON (82046-054-03) / 75 mL in 1 JAR
- ndc1182046-054-01
- ndc1182046-054-02
- ndc1182046-054-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Avobenzone; octisalate; octocrylene in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3b3ff55-eea4-4fea-9224-8fca552164de GET /v1/drugs/d3b3ff55-eea4-4fea-9224-8fca552164de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "30; 50; 70",
"substance": "AVOBENZONE; OCTISALATE; OCTOCRYLENE",
"productndc": "82046-054",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about avobenzone; octisalate; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.